Comparative analysis of biophysical methods for monitoring protein proximity induction in the development of small molecule degraders
Targeted protein degradation relies on inducing proximity between an E3 ubiquitin ligase and a target protein, and subsequent proteasomal degradation of the latter. Biophysical methods allow the measurement of the ternary complex formation by recombinant target and E3 ligase proteins in the presence...
Saved in:
Published in | Biochimica et biophysica acta. General subjects Vol. 1867; no. 9; p. 130398 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.09.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 0304-4165 1872-8006 1872-8006 |
DOI | 10.1016/j.bbagen.2023.130398 |
Cover
Abstract | Targeted protein degradation relies on inducing proximity between an E3 ubiquitin ligase and a target protein, and subsequent proteasomal degradation of the latter. Biophysical methods allow the measurement of the ternary complex formation by recombinant target and E3 ligase proteins in the presence of molecular glues and bifunctional degraders. The development of new chemotypes of degraders mediating ternary complex formation of unknown dimensions and geometries requires the use of different biophysical approaches.
The TR-FRET and AlphaLISA platforms have been applied to study molecular glues and bifunctional degraders. The performance of the label-based proximity assays was compared with the BLI method, which is a label-free, sensor-based approach.
We present and compare two commonly used assays to monitor proximity induction, AlphaLISA and TR-FRET. The LinkScape system consisting of the CaptorBait peptide and the CaptorPrey protein is a novel method of protein labeling compatible with TR-FRET assay.
The TR-FRET and AlphaLISA proximity assays enable detection of ternary complexes formed between an E3 Ligase, a target protein and a small molecule degrader. Experiments with different chemotypes of GSPT1 degraders showed that ALphaLISA was more susceptible to chemotype-dependent interference than TR-FRET assay.
The discovery and optimization of small-molecule inducers of ternary complexes is greatly accelerated by using biophysical assays. The LinkScape-based TR-FRET assay is an alternative to antibody-based proximity assays due to the CaptorPrey's subnanomolar affinity to the CaptorBait-tagged protein target, and the 10-fold lower molecular weight of the CaptorPrey protein compared to the antibody.
[Display omitted]
•Biophysical proximity assays allow monitoring formation of ternary complex.•Protein labeling based on peptide tag derived from bacterial adhesin is described.•LinkScape-based TR-FRET enables detection of protein proximity induced by degraders.•AlphaLISA lacks information about exact stoichiometry between assay components. |
---|---|
AbstractList | Targeted protein degradation relies on inducing proximity between an E3 ubiquitin ligase and a target protein, and subsequent proteasomal degradation of the latter. Biophysical methods allow the measurement of the ternary complex formation by recombinant target and E3 ligase proteins in the presence of molecular glues and bifunctional degraders. The development of new chemotypes of degraders mediating ternary complex formation of unknown dimensions and geometries requires the use of different biophysical approaches.
The TR-FRET and AlphaLISA platforms have been applied to study molecular glues and bifunctional degraders. The performance of the label-based proximity assays was compared with the BLI method, which is a label-free, sensor-based approach.
We present and compare two commonly used assays to monitor proximity induction, AlphaLISA and TR-FRET. The LinkScape system consisting of the CaptorBait peptide and the CaptorPrey protein is a novel method of protein labeling compatible with TR-FRET assay.
The TR-FRET and AlphaLISA proximity assays enable detection of ternary complexes formed between an E3 Ligase, a target protein and a small molecule degrader. Experiments with different chemotypes of GSPT1 degraders showed that ALphaLISA was more susceptible to chemotype-dependent interference than TR-FRET assay.
The discovery and optimization of small-molecule inducers of ternary complexes is greatly accelerated by using biophysical assays. The LinkScape-based TR-FRET assay is an alternative to antibody-based proximity assays due to the CaptorPrey's subnanomolar affinity to the CaptorBait-tagged protein target, and the 10-fold lower molecular weight of the CaptorPrey protein compared to the antibody. Targeted protein degradation relies on inducing proximity between an E3 ubiquitin ligase and a target protein, and subsequent proteasomal degradation of the latter. Biophysical methods allow the measurement of the ternary complex formation by recombinant target and E3 ligase proteins in the presence of molecular glues and bifunctional degraders. The development of new chemotypes of degraders mediating ternary complex formation of unknown dimensions and geometries requires the use of different biophysical approaches. The TR-FRET and AlphaLISA platforms have been applied to study molecular glues and bifunctional degraders. The performance of the label-based proximity assays was compared with the BLI method, which is a label-free, sensor-based approach. We present and compare two commonly used assays to monitor proximity induction, AlphaLISA and TR-FRET. The LinkScape system consisting of the CaptorBait peptide and the CaptorPrey protein is a novel method of protein labeling compatible with TR-FRET assay. The TR-FRET and AlphaLISA proximity assays enable detection of ternary complexes formed between an E3 Ligase, a target protein and a small molecule degrader. Experiments with different chemotypes of GSPT1 degraders showed that ALphaLISA was more susceptible to chemotype-dependent interference than TR-FRET assay. The discovery and optimization of small-molecule inducers of ternary complexes is greatly accelerated by using biophysical assays. The LinkScape-based TR-FRET assay is an alternative to antibody-based proximity assays due to the CaptorPrey's subnanomolar affinity to the CaptorBait-tagged protein target, and the 10-fold lower molecular weight of the CaptorPrey protein compared to the antibody. [Display omitted] •Biophysical proximity assays allow monitoring formation of ternary complex.•Protein labeling based on peptide tag derived from bacterial adhesin is described.•LinkScape-based TR-FRET enables detection of protein proximity induced by degraders.•AlphaLISA lacks information about exact stoichiometry between assay components. Targeted protein degradation relies on inducing proximity between an E3 ubiquitin ligase and a target protein, and subsequent proteasomal degradation of the latter. Biophysical methods allow the measurement of the ternary complex formation by recombinant target and E3 ligase proteins in the presence of molecular glues and bifunctional degraders. The development of new chemotypes of degraders mediating ternary complex formation of unknown dimensions and geometries requires the use of different biophysical approaches.BACKGROUNDTargeted protein degradation relies on inducing proximity between an E3 ubiquitin ligase and a target protein, and subsequent proteasomal degradation of the latter. Biophysical methods allow the measurement of the ternary complex formation by recombinant target and E3 ligase proteins in the presence of molecular glues and bifunctional degraders. The development of new chemotypes of degraders mediating ternary complex formation of unknown dimensions and geometries requires the use of different biophysical approaches.The TR-FRET and AlphaLISA platforms have been applied to study molecular glues and bifunctional degraders. The performance of the label-based proximity assays was compared with the BLI method, which is a label-free, sensor-based approach.METHODSThe TR-FRET and AlphaLISA platforms have been applied to study molecular glues and bifunctional degraders. The performance of the label-based proximity assays was compared with the BLI method, which is a label-free, sensor-based approach.We present and compare two commonly used assays to monitor proximity induction, AlphaLISA and TR-FRET. The LinkScape system consisting of the CaptorBait peptide and the CaptorPrey protein is a novel method of protein labeling compatible with TR-FRET assay.RESULTSWe present and compare two commonly used assays to monitor proximity induction, AlphaLISA and TR-FRET. The LinkScape system consisting of the CaptorBait peptide and the CaptorPrey protein is a novel method of protein labeling compatible with TR-FRET assay.The TR-FRET and AlphaLISA proximity assays enable detection of ternary complexes formed between an E3 Ligase, a target protein and a small molecule degrader. Experiments with different chemotypes of GSPT1 degraders showed that ALphaLISA was more susceptible to chemotype-dependent interference than TR-FRET assay.CONCLUSIONSThe TR-FRET and AlphaLISA proximity assays enable detection of ternary complexes formed between an E3 Ligase, a target protein and a small molecule degrader. Experiments with different chemotypes of GSPT1 degraders showed that ALphaLISA was more susceptible to chemotype-dependent interference than TR-FRET assay.The discovery and optimization of small-molecule inducers of ternary complexes is greatly accelerated by using biophysical assays. The LinkScape-based TR-FRET assay is an alternative to antibody-based proximity assays due to the CaptorPrey's subnanomolar affinity to the CaptorBait-tagged protein target, and the 10-fold lower molecular weight of the CaptorPrey protein compared to the antibody.GENERAL SIGNIFICANCEThe discovery and optimization of small-molecule inducers of ternary complexes is greatly accelerated by using biophysical assays. The LinkScape-based TR-FRET assay is an alternative to antibody-based proximity assays due to the CaptorPrey's subnanomolar affinity to the CaptorBait-tagged protein target, and the 10-fold lower molecular weight of the CaptorPrey protein compared to the antibody. |
ArticleNumber | 130398 |
Author | Statkiewicz, Grzegorz Walczak, Michal J. Brach, Katarzyna Klajn, Jan Przytulski, Kamil Sagan, Maria Glaza, Przemyslaw |
Author_xml | – sequence: 1 givenname: Kamil surname: Przytulski fullname: Przytulski, Kamil email: k.przytulski@captortherapeutics.com organization: Captor Therapeutics Inc, Duńska St 11, PL54427 Wroclaw, Poland – sequence: 2 givenname: Przemyslaw surname: Glaza fullname: Glaza, Przemyslaw email: p.glaza@captortherapeutics.com organization: Captor Therapeutics Inc, Duńska St 11, PL54427 Wroclaw, Poland – sequence: 3 givenname: Katarzyna surname: Brach fullname: Brach, Katarzyna email: k.brach@captortherapeutics.com organization: Captor Therapeutics Inc, Duńska St 11, PL54427 Wroclaw, Poland – sequence: 4 givenname: Maria surname: Sagan fullname: Sagan, Maria email: m.sagan@captortherapeutics.com organization: Captor Therapeutics Inc, Duńska St 11, PL54427 Wroclaw, Poland – sequence: 5 givenname: Grzegorz surname: Statkiewicz fullname: Statkiewicz, Grzegorz email: g.statkiewicz@captortherapeutics.com organization: Captor Therapeutics Inc, Duńska St 11, PL54427 Wroclaw, Poland – sequence: 6 givenname: Jan surname: Klajn fullname: Klajn, Jan email: j.klajn@captortherapeutics.com organization: Captor Therapeutics Inc, Duńska St 11, PL54427 Wroclaw, Poland – sequence: 7 givenname: Michal J. surname: Walczak fullname: Walczak, Michal J. email: michal.walczak@captortherapeutics.com organization: Captor Therapeutics Inc, Duńska St 11, PL54427 Wroclaw, Poland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37301332$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUcGO0zAQtdAitrvwBwj5yCVlEiepwwEJVcCutBIXOFuOPWldOXawnWr7Afw3jrJw4ABzmbH83tPMezfkynmHhLwuYVtC2b47bfteHtBtK6jYtmTAOv6MbEq-qwoO0F6RDTCoi7psm2tyE-MJcjVd84Jcsx2DkrFqQ37u_TjJIJM5I5VO2ks0kfqB9sZPx_xQ0tIR09HrSAcf6OidST4Yd6BT8AmNW_qjGU26UOP0rJLxLk80HZFqPKP104guLaJxlDbLeYtqtsvvIUiNIb4kzwdpI7566rfk--dP3_Z3xcPXL_f7jw-FYm2VinYYOMcmH8QZclCNrvlQaw5Vo0DBTjHdtazLZyqQrRzqst8BZz1oLQfsO3ZL3q66eeUfM8YkRhMVWisd-jmKild120HLIUPfPEHnfkQtpmBGGS7it3UZUK8AFXyMAYc_kBLEkpA4iTUhsSQk1oQy7f1fNGWSXDxLQRr7P_KHlYzZpLPBIKIy6BRqE1Alob35t8AvXNuxJw |
CitedBy_id | crossref_primary_10_1016_j_bioorg_2024_107868 crossref_primary_10_1002_cbic_202400193 crossref_primary_10_1080_17460441_2023_2275640 |
Cites_doi | 10.1021/acsptsci.0c00122 10.1038/nature14610 10.1126/science.1177319 10.1016/j.ab.2004.05.055 10.1074/jbc.RA118.002702 10.1038/s41573-021-00371-6 10.1038/s41573-021-00245-x 10.1177/108705719900400206 10.1016/j.molcel.2017.06.004 10.7554/eLife.38430 10.1111/j.1472-8206.2008.00633.x 10.1038/s41589-018-0055-y 10.1021/acschembio.9b00092 10.1016/0734-9750(94)90292-5 10.1073/pnas.141230798 10.1089/adt.2009.9996 10.1177/108705710200700102 10.1073/pnas.1814446115 10.1038/s41573-019-0047-y 10.1021/acs.jmedchem.1c00895 10.1016/j.bmcl.2008.07.114 10.1074/jbc.RA120.014715 10.1021/ja311795d 10.1038/nature16979 10.1126/science.aab1433 10.1038/nature18611 10.1016/j.jchromb.2004.01.017 10.1038/nature13527 10.1016/j.ddtec.2019.01.002 10.1021/acsptsci.1c00032 10.1182/blood.2020008676 |
ContentType | Journal Article |
Copyright | 2023 Elsevier B.V. Copyright © 2023 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2023 Elsevier B.V. – notice: Copyright © 2023 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION NPM 7X8 |
DOI | 10.1016/j.bbagen.2023.130398 |
DatabaseName | CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1872-8006 |
ExternalDocumentID | 37301332 10_1016_j_bbagen_2023_130398 S030441652300096X |
Genre | Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABEFU ABFNM ABGSF ABMAC ABUDA ABXDB ABYKQ ACDAQ ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OHT OZT P-8 P-9 PC. Q38 R2- ROL RPZ SBG SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K UQL WH7 WUQ XJT XPP ~G- AAHBH AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP BNPGV CITATION SSH NPM 7X8 ACLOT EFKBS ~HD |
ID | FETCH-LOGICAL-c362t-6ff88e516583e80c5d48f4d8025c0c07c3d9639000c0a6af41b7083b0ddafeb93 |
IEDL.DBID | AIKHN |
ISSN | 0304-4165 1872-8006 |
IngestDate | Sat Sep 27 18:06:29 EDT 2025 Wed Feb 19 02:24:23 EST 2025 Tue Jul 01 00:22:18 EDT 2025 Thu Apr 24 22:57:25 EDT 2025 Fri Feb 23 02:36:04 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | Molecular glue Bifunctional degrader Targeted protein degradation TR-FRET Ternary complex formation Protein labeling |
Language | English |
License | Copyright © 2023 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c362t-6ff88e516583e80c5d48f4d8025c0c07c3d9639000c0a6af41b7083b0ddafeb93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 37301332 |
PQID | 2824690680 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2824690680 pubmed_primary_37301332 crossref_primary_10_1016_j_bbagen_2023_130398 crossref_citationtrail_10_1016_j_bbagen_2023_130398 elsevier_sciencedirect_doi_10_1016_j_bbagen_2023_130398 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | September 2023 2023-09-00 2023-Sep 20230901 |
PublicationDateYYYYMMDD | 2023-09-01 |
PublicationDate_xml | – month: 09 year: 2023 text: September 2023 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Biochimica et biophysica acta. General subjects |
PublicationTitleAlternate | Biochim Biophys Acta Gen Subj |
PublicationYear | 2023 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Dong, Ding, He, Sheng (bb0010) 2021; 64 Békés, Langley, Crews (bb0015) 2022; 21 Nowak, Deangelo, Buckley, He, Donovan, An, Safaee, Jedrychowski, Ponthier, Ishoey, Zhang, Mancias, Gray, Bradner, Fischer (bb0085) 2018; 14 Schneekloth, Pucheault, Tae, Crews (bb0030) 2008; 18 Fischer (bb0130) 1994; 12 Schapira, Calabrese, Bullock, Crews (bb0005) 2019; 18 Guhathakurta, Prochniewicz, Grant, Peterson, Thomas (bb0075) 2018; 293 Matyskiela, Lu, Ito, Pagarigan, Lu, Miller, Fang, Wang, Nguyen, Houston, Carmel, Tran, Riley, Nosaka, Lander, Gaidarova, Xu, Ruchelman, Handa, Carmichael, Daniel, Cathers, Lopez-Girona, Chamberlain (bb0050) 2016; 535 Surka, Jin, Mbong, Lu, Jang, Rychak, Mendy, Clayton, Tindall, Hsu, Fontanillo, Tran, Contreras, Ng, Matyskiela, Wang, Chamberlain, Cathers, Carmichael, Hansen, Wang, Minden, Fan, Pierce, Pourdehnad, Rolfe, Lopez-Girona, Dick, Lu (bb0105) 2021; 137 Schasfoort (bb0200) 2017 Donovan, An, Nowak, Yuan, Fink, Berry, Ebert, Fischer (bb0065) 2018; 7 Bahmanyar, Calabrese, CASHION, Cathers, CORREA, DELGADO, Hansen, Hegde, Huang, Leftheris (bb0115) 2015 Lin, Williams, Murray, Conn, Ropp (bb0125) 2004; 803 Roy, Winkler, Hughes, Whitworth, Galant, Farnaby, Rumpel, Ciulli (bb0195) 2019; 14 (bb0180) 2022 Han (bb0150) 2020; 295 Markossian, Grossman, Brimacombe (bb0160) 2004 Sakamoto, Kim, Kumagai, Mercurio, Crews, Deshaies (bb0025) 2001; 98 Chan, Erdman, Fung, Hecht, Lam, Sullivan, Torres (bb0110) 2022 Goutelle, Maurin, Rougier, Barbaut, Bourguignon, Ducher, Maire (bb0155) 2008; 22 Ito, Ando, Suzuki, Ogura, Hotta, Imamura, Yamaguchi, Handa (bb0040) 2010; 327 Gorshkov, Chen, Xu, Carlos De La Torre, Martinez-Sobrido, Moran, Zheng (bb0080) 2020; 3 Gemechu, Millrine, Hashimoto, Prakash, Sanchenkova, Metwally, Gyanu, Kang, Kishimoto (bb0120) 2018; 115 Winter, Buckley, Paulk, Roberts, Souza, Dhe-Paganon, Bradner (bb0090) 2015; 348 Bosse, Illy, Chelsky (bb0185) 2002 Lakowicz (bb0170) 2006 Petzold, Fischer, Thomä (bb0055) 2016; 532 Schneider, Radoux, Hercules, Ochoa, Dunham, Zalmas, Hessler, Ruf, Shanmugasundaram, Hann, Thomas, Queisser, Benowitz, Brown, Leach (bb0020) 2021; 20 Lenz (bb0035) 1966; 112 Glickman, Wu, Mercuri, Illy, Bowen, He, Sills (bb0070) 2002; 7 Zhang, Chung, Oldenburg (bb0165) 1999; 4 Krönke, Fink, Hollenbach, MacBeth, Hurst, Udeshi, Chamberlain, Mani, Man, Gandhi, Svinkina, Schneider, McConkey, Järås, Griffiths, Wetzler, Bullinger, Cathers, Carr, Chopra, Ebert (bb0060) 2015; 523 Lin, Chen (bb0100) 2021 Nikolovska-Coleska, Wang, Fang, Pan, Tomita, Li, Roller, Krajewski, Saito, Stuckey, Wang (bb0140) 2004; 332 Peleg, Prabahar, Bednarczyk, Unger (bb0135) 2017; 1586 Fischer, Böhm, Lydeard, Yang, Stadler, Cavadini, Nagel, Serluca, Acker, Lingaraju, Tichkule, Schebesta, Forrester, Schirle, Hassiepen, Ottl, Hild, Beckwith, Harper, Jenkins, Thomä (bb0045) 2014; 512 Pettersson, Crews (bb0175) 2019; 31 Bielefeld-Sevigny (bb0190) 2009; 7 Winter, Mayer, Buckley, Erb, Roderick, Vittori, Reyes, di Iulio, Souza, Ott, Roberts, Zeid, Scott, Paulk, Lachance, Olson, Dastjerdi, Bauer, Lin, Gray, Kelliher, Churchman, Bradner (bb0095) 2017; 67 Douglass, Miller, Sparer, Shapiro, Spiegel (bb0145) 2013; 135 Schapira (10.1016/j.bbagen.2023.130398_bb0005) 2019; 18 Gemechu (10.1016/j.bbagen.2023.130398_bb0120) 2018; 115 Schasfoort (10.1016/j.bbagen.2023.130398_bb0200) 2017 Sakamoto (10.1016/j.bbagen.2023.130398_bb0025) 2001; 98 Pettersson (10.1016/j.bbagen.2023.130398_bb0175) 2019; 31 Schneekloth (10.1016/j.bbagen.2023.130398_bb0030) 2008; 18 Bosse (10.1016/j.bbagen.2023.130398_bb0185) 2002 Peleg (10.1016/j.bbagen.2023.130398_bb0135) 2017; 1586 Lakowicz (10.1016/j.bbagen.2023.130398_bb0170) 2006 Fischer (10.1016/j.bbagen.2023.130398_bb0045) 2014; 512 Goutelle (10.1016/j.bbagen.2023.130398_bb0155) 2008; 22 Matyskiela (10.1016/j.bbagen.2023.130398_bb0050) 2016; 535 Surka (10.1016/j.bbagen.2023.130398_bb0105) 2021; 137 Dong (10.1016/j.bbagen.2023.130398_bb0010) 2021; 64 Zhang (10.1016/j.bbagen.2023.130398_bb0165) 1999; 4 Winter (10.1016/j.bbagen.2023.130398_bb0090) 2015; 348 Gorshkov (10.1016/j.bbagen.2023.130398_bb0080) 2020; 3 Lin (10.1016/j.bbagen.2023.130398_bb0125) 2004; 803 Roy (10.1016/j.bbagen.2023.130398_bb0195) 2019; 14 Guhathakurta (10.1016/j.bbagen.2023.130398_bb0075) 2018; 293 Chan (10.1016/j.bbagen.2023.130398_bb0110) 2022 Han (10.1016/j.bbagen.2023.130398_bb0150) 2020; 295 Donovan (10.1016/j.bbagen.2023.130398_bb0065) 2018; 7 Nowak (10.1016/j.bbagen.2023.130398_bb0085) 2018; 14 Fischer (10.1016/j.bbagen.2023.130398_bb0130) 1994; 12 Bahmanyar (10.1016/j.bbagen.2023.130398_bb0115) Bielefeld-Sevigny (10.1016/j.bbagen.2023.130398_bb0190) 2009; 7 Winter (10.1016/j.bbagen.2023.130398_bb0095) 2017; 67 Markossian (10.1016/j.bbagen.2023.130398_bb0160) 2004 Lenz (10.1016/j.bbagen.2023.130398_bb0035) 1966; 112 Krönke (10.1016/j.bbagen.2023.130398_bb0060) 2015; 523 Nikolovska-Coleska (10.1016/j.bbagen.2023.130398_bb0140) 2004; 332 Békés (10.1016/j.bbagen.2023.130398_bb0015) 2022; 21 Ito (10.1016/j.bbagen.2023.130398_bb0040) 2010; 327 Glickman (10.1016/j.bbagen.2023.130398_bb0070) 2002; 7 Schneider (10.1016/j.bbagen.2023.130398_bb0020) 2021; 20 Lin (10.1016/j.bbagen.2023.130398_bb0100) 2021 Douglass (10.1016/j.bbagen.2023.130398_bb0145) 2013; 135 Petzold (10.1016/j.bbagen.2023.130398_bb0055) 2016; 532 |
References_xml | – volume: 7 start-page: 90 year: 2009 end-page: 92 ident: bb0190 article-title: AlphaLISA immunoassay platform- the “no-Wash” high-throughput alternative to ELISA publication-title: Assay Drug Dev. Technol. – volume: 22 start-page: 633 year: 2008 end-page: 648 ident: bb0155 article-title: The hill equation: a review of its capabilities in pharmacological modelling publication-title: Fundam. Clin. Pharmacol. – volume: 7 year: 2018 ident: bb0065 article-title: Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane radial ray syndrome publication-title: Elife. – volume: 1586 start-page: 33 year: 2017 end-page: 43 ident: bb0135 article-title: Heterologous Gene Expression in E.coli – start-page: 1 year: 2017 end-page: 26 ident: bb0200 article-title: Introduction to surface plasmon resonance publication-title: Handb. Surf. Plasmon Reson., (2), The Royal Society of Chemistry – volume: 14 start-page: 361 year: 2019 end-page: 368 ident: bb0195 article-title: SPR-measured dissociation kinetics of PROTAC ternary complexes influence target degradation rate publication-title: ACS Chem. Biol. – year: 2022 ident: bb0110 article-title: Protein-targeting compounds and pharmaceutical compositions thereof, and their therapeutic applications, (2022) Biotheryx Inc. Publication Number: WO/2020/242960. International Application Number: PCT/US2020/034264 – year: 2002 ident: bb0185 article-title: Principles of AlphaScreen, Amplified Luminescent Proximity Homogenous Assay, AlphaScreen Appl. Note – volume: 532 start-page: 127 year: 2016 end-page: 130 ident: bb0055 article-title: Structural basis of lenalidomide-induced CK1α degradation by the CRL4 CRBN ubiquitin ligase publication-title: Nature. – year: 2006 ident: bb0170 article-title: Principles of Fluorescence Spectroscopy – volume: 115 start-page: 11802 year: 2018 end-page: 11807 ident: bb0120 article-title: Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 512 start-page: 49 year: 2014 end-page: 53 ident: bb0045 article-title: Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide publication-title: Nature. – volume: 7 start-page: 3 year: 2002 end-page: 10 ident: bb0070 article-title: A comparison of ALPHAscreen, TR-FRET, and TRF as assay methods for FXR nuclear receptors publication-title: J. Biomol. Screen. – volume: 4 start-page: 67 year: 1999 end-page: 73 ident: bb0165 article-title: A simple statistical parameter for use in evaluation and validation of high throughput screening assays publication-title: J. Biomol. Screen. – volume: 14 start-page: 706 year: 2018 end-page: 714 ident: bb0085 article-title: Plasticity in binding confers selectivity in ligand-induced protein degradation article publication-title: Nat. Chem. Biol. – year: 2021 ident: bb0100 article-title: General stepwise approach to optimize a TR-FRET assay for characterizing the BRD/PROTAC/CRBN ternary complex publication-title: ACS Pharmacol. Transl. Sci. – volume: 332 start-page: 261 year: 2004 end-page: 273 ident: bb0140 article-title: Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization publication-title: Anal. Biochem. – volume: 18 start-page: 5904 year: 2008 end-page: 5908 ident: bb0030 article-title: Targeted intracellular protein degradation induced by a small molecule: en route to chemical proteomics, bioorganic med publication-title: Chem. Lett. – volume: 64 start-page: 10606 year: 2021 end-page: 10620 ident: bb0010 article-title: Molecular glues for targeted protein degradation: from serendipity to rational discovery publication-title: J. Med. Chem. – volume: 20 start-page: 789 year: 2021 end-page: 797 ident: bb0020 article-title: The PROTACtable genome publication-title: Nat. Rev. Drug Discov. – volume: 12 start-page: 89 year: 1994 end-page: 101 ident: bb0130 article-title: Renaturation of recombinant proteins produced as inclusion bodies publication-title: Biotechnol. Adv. – volume: 803 start-page: 353 year: 2004 end-page: 362 ident: bb0125 article-title: Ion chromatographic quantification of cyanate in urea solutions: estimation of the efficiency of cyanate scavengers for use in recombinant protein manufacturing publication-title: J. Chromatogr. B Anal. Technol. Biomed. Life Sci. – volume: 295 start-page: 15280 year: 2020 end-page: 15291 ident: bb0150 article-title: A suite of mathematical solutions to describe ternary complex formation and their application to targeted protein degradation by heterobifunctional ligands publication-title: J. Biol. Chem. – volume: 31 start-page: 15 year: 2019 end-page: 27 ident: bb0175 article-title: PROteolysis TArgeting chimeras (PROTACs) — past, present and future publication-title: Drug Discov. Today Technol. – volume: 98 start-page: 8554 year: 2001 end-page: 8559 ident: bb0025 article-title: Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 67 start-page: 5 year: 2017 end-page: 18.e19 ident: bb0095 article-title: BET Bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment publication-title: Mol. Cell – year: 2022 ident: bb0180 article-title: Prism 9 Curve Fitting guide, Equation: Bell-shaped dose-response – volume: 21 start-page: 181 year: 2022 end-page: 200 ident: bb0015 article-title: PROTAC targeted protein degraders: the past is prologue publication-title: Nat. Rev. Drug Discov. – volume: 523 start-page: 183 year: 2015 end-page: 188 ident: bb0060 article-title: Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS publication-title: Nature. – year: 2004 ident: bb0160 article-title: Assay Guidance Manual [Internet] – volume: 535 start-page: 252 year: 2016 end-page: 257 ident: bb0050 article-title: A novel cereblon modulator recruits GSPT1 to the CRL4 CRBN ubiquitin ligase publication-title: Nature. – volume: 18 start-page: 949 year: 2019 end-page: 963 ident: bb0005 article-title: Targeted protein degradation: expanding the toolbox publication-title: Nat. Rev. Drug Discov. – volume: 293 start-page: 12288 year: 2018 end-page: 12298 ident: bb0075 article-title: High-throughput screen, using time-resolved FRET, yields actin-binding compounds that modulate actin–myosin structure and function publication-title: J. Biol. Chem. – volume: 137 start-page: 661 year: 2021 end-page: 677 ident: bb0105 article-title: CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells publication-title: Blood. – volume: 135 start-page: 6092 year: 2013 end-page: 6099 ident: bb0145 article-title: A comprehensive mathematical model for three-body binding equilibria publication-title: J. Am. Chem. Soc. – year: 2015 ident: bb0115 article-title: Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith, (2020) Celgene Corp. Publication number: WO/2020/243379 – volume: 112 start-page: 99 year: 1966 end-page: 106 ident: bb0035 article-title: Malformations caused by drugs in pregnancy publication-title: Am. J. Dis. Child. – volume: 327 start-page: 1345 year: 2010 end-page: 1350 ident: bb0040 article-title: Identification of a primary target of thalidomide teratogenicity publication-title: Science (80-.) – volume: 3 start-page: 1233 year: 2020 end-page: 1241 ident: bb0080 article-title: Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 nucleocapsid publication-title: ACS Pharmacol. Transl. Sci. – volume: 348 start-page: 1376 year: 2015 end-page: 1381 ident: bb0090 article-title: Phthalimide conjugation as a strategy for in vivo target protein degradation publication-title: Science (80-.) – volume: 3 start-page: 1233 year: 2020 ident: 10.1016/j.bbagen.2023.130398_bb0080 article-title: Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 nucleocapsid publication-title: ACS Pharmacol. Transl. Sci. doi: 10.1021/acsptsci.0c00122 – volume: 1586 start-page: 33 year: 2017 ident: 10.1016/j.bbagen.2023.130398_bb0135 – volume: 523 start-page: 183 year: 2015 ident: 10.1016/j.bbagen.2023.130398_bb0060 article-title: Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS publication-title: Nature. doi: 10.1038/nature14610 – year: 2004 ident: 10.1016/j.bbagen.2023.130398_bb0160 – volume: 327 start-page: 1345 year: 2010 ident: 10.1016/j.bbagen.2023.130398_bb0040 article-title: Identification of a primary target of thalidomide teratogenicity publication-title: Science (80-.) doi: 10.1126/science.1177319 – start-page: 1 year: 2017 ident: 10.1016/j.bbagen.2023.130398_bb0200 article-title: Introduction to surface plasmon resonance – year: 2022 ident: 10.1016/j.bbagen.2023.130398_bb0110 – ident: 10.1016/j.bbagen.2023.130398_bb0115 – volume: 332 start-page: 261 year: 2004 ident: 10.1016/j.bbagen.2023.130398_bb0140 article-title: Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization publication-title: Anal. Biochem. doi: 10.1016/j.ab.2004.05.055 – volume: 293 start-page: 12288 year: 2018 ident: 10.1016/j.bbagen.2023.130398_bb0075 article-title: High-throughput screen, using time-resolved FRET, yields actin-binding compounds that modulate actin–myosin structure and function publication-title: J. Biol. Chem. doi: 10.1074/jbc.RA118.002702 – volume: 21 start-page: 181 year: 2022 ident: 10.1016/j.bbagen.2023.130398_bb0015 article-title: PROTAC targeted protein degraders: the past is prologue publication-title: Nat. Rev. Drug Discov. doi: 10.1038/s41573-021-00371-6 – volume: 20 start-page: 789 year: 2021 ident: 10.1016/j.bbagen.2023.130398_bb0020 article-title: The PROTACtable genome publication-title: Nat. Rev. Drug Discov. doi: 10.1038/s41573-021-00245-x – volume: 4 start-page: 67 year: 1999 ident: 10.1016/j.bbagen.2023.130398_bb0165 article-title: A simple statistical parameter for use in evaluation and validation of high throughput screening assays publication-title: J. Biomol. Screen. doi: 10.1177/108705719900400206 – volume: 67 start-page: 5 year: 2017 ident: 10.1016/j.bbagen.2023.130398_bb0095 article-title: BET Bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment publication-title: Mol. Cell doi: 10.1016/j.molcel.2017.06.004 – volume: 7 year: 2018 ident: 10.1016/j.bbagen.2023.130398_bb0065 article-title: Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane radial ray syndrome publication-title: Elife. doi: 10.7554/eLife.38430 – volume: 22 start-page: 633 year: 2008 ident: 10.1016/j.bbagen.2023.130398_bb0155 article-title: The hill equation: a review of its capabilities in pharmacological modelling publication-title: Fundam. Clin. Pharmacol. doi: 10.1111/j.1472-8206.2008.00633.x – volume: 14 start-page: 706 year: 2018 ident: 10.1016/j.bbagen.2023.130398_bb0085 article-title: Plasticity in binding confers selectivity in ligand-induced protein degradation article publication-title: Nat. Chem. Biol. doi: 10.1038/s41589-018-0055-y – year: 2002 ident: 10.1016/j.bbagen.2023.130398_bb0185 – volume: 14 start-page: 361 year: 2019 ident: 10.1016/j.bbagen.2023.130398_bb0195 article-title: SPR-measured dissociation kinetics of PROTAC ternary complexes influence target degradation rate publication-title: ACS Chem. Biol. doi: 10.1021/acschembio.9b00092 – volume: 12 start-page: 89 year: 1994 ident: 10.1016/j.bbagen.2023.130398_bb0130 article-title: Renaturation of recombinant proteins produced as inclusion bodies publication-title: Biotechnol. Adv. doi: 10.1016/0734-9750(94)90292-5 – volume: 98 start-page: 8554 year: 2001 ident: 10.1016/j.bbagen.2023.130398_bb0025 article-title: Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.141230798 – volume: 7 start-page: 90 year: 2009 ident: 10.1016/j.bbagen.2023.130398_bb0190 article-title: AlphaLISA immunoassay platform- the “no-Wash” high-throughput alternative to ELISA publication-title: Assay Drug Dev. Technol. doi: 10.1089/adt.2009.9996 – volume: 7 start-page: 3 year: 2002 ident: 10.1016/j.bbagen.2023.130398_bb0070 article-title: A comparison of ALPHAscreen, TR-FRET, and TRF as assay methods for FXR nuclear receptors publication-title: J. Biomol. Screen. doi: 10.1177/108705710200700102 – volume: 115 start-page: 11802 year: 2018 ident: 10.1016/j.bbagen.2023.130398_bb0120 article-title: Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1814446115 – volume: 18 start-page: 949 year: 2019 ident: 10.1016/j.bbagen.2023.130398_bb0005 article-title: Targeted protein degradation: expanding the toolbox publication-title: Nat. Rev. Drug Discov. doi: 10.1038/s41573-019-0047-y – volume: 64 start-page: 10606 year: 2021 ident: 10.1016/j.bbagen.2023.130398_bb0010 article-title: Molecular glues for targeted protein degradation: from serendipity to rational discovery publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.1c00895 – volume: 18 start-page: 5904 year: 2008 ident: 10.1016/j.bbagen.2023.130398_bb0030 article-title: Targeted intracellular protein degradation induced by a small molecule: en route to chemical proteomics, bioorganic med publication-title: Chem. Lett. doi: 10.1016/j.bmcl.2008.07.114 – year: 2006 ident: 10.1016/j.bbagen.2023.130398_bb0170 – volume: 295 start-page: 15280 year: 2020 ident: 10.1016/j.bbagen.2023.130398_bb0150 article-title: A suite of mathematical solutions to describe ternary complex formation and their application to targeted protein degradation by heterobifunctional ligands publication-title: J. Biol. Chem. doi: 10.1074/jbc.RA120.014715 – volume: 135 start-page: 6092 year: 2013 ident: 10.1016/j.bbagen.2023.130398_bb0145 article-title: A comprehensive mathematical model for three-body binding equilibria publication-title: J. Am. Chem. Soc. doi: 10.1021/ja311795d – volume: 112 start-page: 99 year: 1966 ident: 10.1016/j.bbagen.2023.130398_bb0035 article-title: Malformations caused by drugs in pregnancy publication-title: Am. J. Dis. Child. – volume: 532 start-page: 127 year: 2016 ident: 10.1016/j.bbagen.2023.130398_bb0055 article-title: Structural basis of lenalidomide-induced CK1α degradation by the CRL4 CRBN ubiquitin ligase publication-title: Nature. doi: 10.1038/nature16979 – volume: 348 start-page: 1376 year: 2015 ident: 10.1016/j.bbagen.2023.130398_bb0090 article-title: Phthalimide conjugation as a strategy for in vivo target protein degradation publication-title: Science (80-.) doi: 10.1126/science.aab1433 – volume: 535 start-page: 252 year: 2016 ident: 10.1016/j.bbagen.2023.130398_bb0050 article-title: A novel cereblon modulator recruits GSPT1 to the CRL4 CRBN ubiquitin ligase publication-title: Nature. doi: 10.1038/nature18611 – volume: 803 start-page: 353 year: 2004 ident: 10.1016/j.bbagen.2023.130398_bb0125 article-title: Ion chromatographic quantification of cyanate in urea solutions: estimation of the efficiency of cyanate scavengers for use in recombinant protein manufacturing publication-title: J. Chromatogr. B Anal. Technol. Biomed. Life Sci. doi: 10.1016/j.jchromb.2004.01.017 – volume: 512 start-page: 49 year: 2014 ident: 10.1016/j.bbagen.2023.130398_bb0045 article-title: Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide publication-title: Nature. doi: 10.1038/nature13527 – volume: 31 start-page: 15 year: 2019 ident: 10.1016/j.bbagen.2023.130398_bb0175 article-title: PROteolysis TArgeting chimeras (PROTACs) — past, present and future publication-title: Drug Discov. Today Technol. doi: 10.1016/j.ddtec.2019.01.002 – year: 2021 ident: 10.1016/j.bbagen.2023.130398_bb0100 article-title: General stepwise approach to optimize a TR-FRET assay for characterizing the BRD/PROTAC/CRBN ternary complex publication-title: ACS Pharmacol. Transl. Sci. doi: 10.1021/acsptsci.1c00032 – volume: 137 start-page: 661 year: 2021 ident: 10.1016/j.bbagen.2023.130398_bb0105 article-title: CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells publication-title: Blood. doi: 10.1182/blood.2020008676 |
SSID | ssj0000595 |
Score | 2.4321368 |
Snippet | Targeted protein degradation relies on inducing proximity between an E3 ubiquitin ligase and a target protein, and subsequent proteasomal degradation of the... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 130398 |
SubjectTerms | Bifunctional degrader Molecular glue Protein labeling Targeted protein degradation Ternary complex formation TR-FRET |
Title | Comparative analysis of biophysical methods for monitoring protein proximity induction in the development of small molecule degraders |
URI | https://dx.doi.org/10.1016/j.bbagen.2023.130398 https://www.ncbi.nlm.nih.gov/pubmed/37301332 https://www.proquest.com/docview/2824690680 |
Volume | 1867 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1872-8006 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000595 issn: 0304-4165 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection [SCCMFC] customDbUrl: eissn: 1872-8006 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000595 issn: 0304-4165 databaseCode: ACRLP dateStart: 19950118 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection customDbUrl: eissn: 1872-8006 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000595 issn: 0304-4165 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1872-8006 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000595 issn: 0304-4165 databaseCode: AIKHN dateStart: 19950118 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1872-8006 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000595 issn: 0304-4165 databaseCode: AKRWK dateStart: 19640113 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7xUFUuiNIWFlpkJK7uJnEezhGtQNtW5dIi7c2KX9VWkF2xiwQXbvxvZmKHVQ8IiVMejh3LY898tsfzAZxY11SlySpeuVTyPPWC14nJuM2FqF2ambLzJvx1UY4v8x-TYrIGo_4sDLlVRt0fdHqnreObYWzN4Xw6Hf6mTT2EE7SsSUB8sg6bGVp7nIFtnn7_Ob5YKeSiI1-h7zll6E_QdW5eWuO4pUComSBmZFHLlyzUSwi0s0TnO7AdISQ7DbX8AGuu3YV3gVTyfhfej3oOt4_wOFoF92ZNjD_CZp7p6WweJcQCifSCIXxl190Qp7U-1kVwmLZ0vaNTUPcMp-8h1izeMQSOzK48jqjQxXVzhcUFwl1K_XvT-Ul_gsvzsz-jMY_EC9ygPVvy0nspXYFNJYWTiSlsLn1uJeIjk5ikMsLiuCW6UZM0ZePzVFcI5XRibeOdrsVn2GhnrdsHVmOiTRMtvHF5YwxOX3xemKLSxiB4EgMQfWMrE6OSEznGlerdz_6pICJFIlJBRAPgz7nmISrHK99XvRzVf71LoeF4JedxL3aFsqPdlKZ1s9uFwrkqLS2UMhnAXugPz3URpDeFyA7e_N9D2KKn4M32BTaWN7fuK8KfpT6C9W8P6VHs5E_g0gYQ |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RUEUvqNAWtg9wpV7dTWIncY5oVbTldSlIe7PiV7UIsit2kcqlt_7vzsQJKw4IiVOi-BHLMx5_tj_PAHxzvi4Lm5W89KniMg2CV4nNuJNCVD7NbNGyCc_Oi_GlPJ7kkzUY9XdhiFbZ2f5o01tr3X0Zdr05nE-nw190qIdwgrY1CYhPXsGGJI1Cpf7-d8XzQPyQx6MEySl7f3-uJXkZg6OW3KBmguIii0o9NT89hT_beejoLWx1AJIdxjZuw5pvduB1DCl5vwOboz6C2zv4N1q59mZ1532EzQIz09m8kw-LIaQXDMEru2kHOO30sdZ_w7Sh5x-6A3XPcPEePc3iG0PYyNyKb0SVLm7qa6wuhtul1N-3LUv6PVwe_bgYjXkXdoFbnM2WvAhBKZ9jVynhVWJzJ1WQTiE6solNSiscjloKNmqTuqiDTE2JQM4kztXBm0p8gPVm1vg9YBUmujQxIlgva2tx8RJkbvPSWIvQSQxA9J2tbeeTnEJjXOuefHalo4g0iUhHEQ2AP5SaR58cz-QveznqR7qlcdp4puTXXuwaZUdnKXXjZ3cLjStV2lgoVDKA3agPD20RZDWFyD6--L8HsDm-ODvVpz_PTz7BG0qJvLbPsL68vfNfEAgtzX6r6P8BHesG2w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparative+analysis+of+biophysical+methods+for+monitoring+protein+proximity+induction+in+the+development+of+small+molecule+degraders&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Przytulski%2C+Kamil&rft.au=Glaza%2C+Przemyslaw&rft.au=Brach%2C+Katarzyna&rft.au=Sagan%2C+Maria&rft.date=2023-09-01&rft.eissn=1872-8006&rft.volume=1867&rft.issue=9&rft.spage=130398&rft_id=info:doi/10.1016%2Fj.bbagen.2023.130398&rft_id=info%3Apmid%2F37301332&rft.externalDocID=37301332 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon |